Ioannis K Zervantonakis

ResearcherID Loop profile Scopus Author ID Pitt ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

bioRxiv : the preprint server for biology

PLoS computational biology

Advanced healthcare materials

APL bioengineering

University of Pittsburgh

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Sep 01 2019

United States

Assistant Professor :: Bioengineering

Education History

Massachusetts Institute of Technology

United States

PHD :: Mechanical Engineering

Publications

Alexis L Scott, Dorota E Jazwinska, Diana G Kulawiec, Ioannis K Zervantonakis
Paracrine Ovarian Cancer Cell-Derived CSF1 Signaling Regulates Macrophage Migration Dynamics in a 3D Microfluidic Model that Recapitulates in vivo Infiltration Patterns in Patient-Derived Xenografts. Advanced healthcare materials (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Youngbin Cho, Matthew Laird, Teddi Bishop, Ruxuan Li, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays. bioRxiv : the preprint server for biology (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Youngbin Cho, Matthew S Laird, Teddi Bishop, Ruxuan Li, Dorota E Jazwinska, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays. APL bioengineering 8 (3) (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Youngbin Cho, Matthew Laird, Teddi Bishop, Ruxuan Li, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays. bioRxiv : the preprint server for biology (2024)
Youngbin Cho, Matthew Laird, Teddi Bishop, Ruxuan Li, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays. bioRxiv : the preprint server for biology (2024)
Youngbin Cho, Matthew S Laird, Teddi Bishop, Ruxuan Li, Dorota E Jazwinska, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays. APL bioengineering 8 (3) (2024)
Alexis L Scott, Dorota E Jazwinska, Diana G Kulawiec, Ioannis K Zervantonakis
Paracrine Ovarian Cancer Cell-Derived CSF1 Signaling Regulates Macrophage Migration Dynamics in a 3D Microfluidic Model that Recapitulates In Vivo Infiltration Patterns in Patient-Derived Xenografts. Advanced healthcare materials (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Matthew D Poskus, Tuo Wang, Yuxuan Deng, Sydney Borcherding, Jake Atkinson, Ioannis K Zervantonakis
Fabrication of 3D-printed molds for polydimethylsiloxane-based microfluidic devices using a liquid crystal display-based vat photopolymerization process: printing quality, drug response and 3D invasion cell culture assays. Microsystems & nanoengineering 9 (2023)
Marilyne Labrie, Joan S Brugge, Gordon B Mills, Ioannis K Zervantonakis
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nature reviews. Cancer 22 (6) (2022)
N Mohammad Mirzaei, Navid Changizi, Alireza Asadpoure, Sumeyye Su, Dilruba Sofia, Zuzana Tatarova, Ioannis K Zervantonakis, Young Hwan Chang, Leili Shahriyari
Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model. PLoS computational biology 18 (3) (2022)
Ioannis K Zervantonakis, Matthew D Poskus, Alexis L Scott, Laura M Selfors, Jia-Ren Lin, Deborah A Dillon, Shailja Pathania, Peter K Sorger, Gordon B Mills, Joan S Brugge
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proceedings of the National Academy of Sciences of the United States of America 117 (28) (2020)
Elin Nyman, Richard R Stein, Xiaohong Jing, Weiqing Wang, Benjamin Marks, Ioannis K Zervantonakis, Anil Korkut, Nicholas P Gauthier, Chris Sander
Perturbation biology links temporal protein changes to drug responses in a melanoma cell line. PLoS computational biology 16 (7) (2020)
Claudia Iavarone, Ioannis K Zervantonakis, Laura M Selfors, Sangeetha Palakurthi, Joyce F Liu, Ronny Drapkin, Ursula A Matulonis, Dorothy Hallberg, Victor E Velculescu, Joel D Leverson, Deepak Sampath, Gordon B Mills, Joan S Brugge
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness. Molecular cancer therapeutics 18 (3) (2019)
Elizabeth H Stover, Maria B Baco, Ofir Cohen, Yvonne Y Li, Elizabeth L Christie, Mukta Bagul, Amy Goodale, Yenarae Lee, Sasha Pantel, Matthew G Rees, Guo Wei, Adam G Presser, Maya K Gelbard, Weiqun Zhang, Ioannis K Zervantonakis, Patrick D Bhola, Jeremy Adam Ryan, Jennifer L Guerriero, Joan Montero, Felice J Liang, Andrew D Cherniak, Federica Piccioni, Ursula A Matulonis, David D L Bowtell, Kristopher A Sarosiek, Anthony Letai, Levi A Garraway, Cory M Johannessen, Matthew Meyerson
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer. Molecular cancer research : MCR 17 (11) (2019)
Siranush Sarkizova, Susan Klaeger, Phuong M Le, Letitia W Li, Giacomo Oliveira, Hasmik Keshishian, Christina R Hartigan, Wandi Zhang, David A Braun, Keith L Ligon, Pavan Bachireddy, Ioannis K Zervantonakis, Jennifer M Rosenbluth, Tamara Ouspenskaia, Travis Law, Sune Justesen, Jonathan Stevens, William J Lane, Thomas Eisenhaure, Guang Lan Zhang, Karl R Clauser, Nir Hacohen, Steven A Carr, Catherine J Wu, Derin B Keskin
A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nature biotechnology 38 (2) (2019)
Ioannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, Laura M Selfors, Sangeetha Palakurthi, Joyce F Liu, Ronny Drapkin, Ursula Matulonis, Joel D Leverson, Deepak Sampath, Gordon B Mills, Joan S Brugge
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. Nature communications 8 (1) (2017)

Ioannis K Zervantonakis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ioannis K Zervantonakis